Molecular targeted therapies work by interfering with specific pathways that are critical for the survival, growth, and spread of cancer cells. These pathways often involve proteins or genes that are mutated or overexpressed in cancer cells. By blocking these pathways, targeted therapies can help to inhibit the proliferation or induce the death of cancer cells.